KYTX

Kyverna Therapeutics, Inc. - Common Stock (KYTX)

About Kyverna Therapeutics, Inc. - Common Stock (KYTX)

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Details

Daily high

$7.26

Daily low

$6.99

Price at open

$7.25

52 Week High

$13.67

52 Week Low

$5.27

Market cap

440.9M

Dividend yield

Volume

501,656

Avg. volume

714,331

P/E ratio

-2.43

Kyverna Therapeutics, Inc. - Common Stock News